本页面由Tiger Trade Technology Pte. Ltd.提供服务

10x Genomics, Inc.

20.46
-0.4500-2.15%
成交量:171.22万
成交额:3,504.72万
市值:26.13亿
市盈率:-58.62
高:21.23
开:21.04
低:20.06
收:20.91
52周最高:23.56
52周最低:6.78
股本:1.28亿
流通股本:1.15亿
量比:0.90
换手率:1.49%
股息:- -
股息率:- -
每股收益(TTM):-0.3490
每股收益(LYR):-0.3490
净资产收益率:-5.78%
总资产收益率:-6.40%
市净率:3.28
市盈率(LYR):-58.62

数据加载中...

2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/13

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/02/13

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/12

重要事件披露

Form 8-K - Current report
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/11/14

重要事件披露

Form 8-K - Current report
2025/11/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/11/07

重要事件披露

Form 8-K - Current report
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/08/08

重要事件披露

Form 8-K - Current report